StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca fluMist / Fluenz (influenza vaccine) — Worldwide YoY CER (%) (%)

Form 6-K / 20-F Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
78.0%
Period ended Jun 30, 2026
Change on a year earlier
–
History
12 quarters
Since Q4 2020
Sources
12
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFluMist / Fluenz (influenza vaccine) — Worldwide YoY CER (%) (%)Year on yearSource
Q2 2026Jun 30, 202678.0%–Form 6-K FY2026Q2 Earnings Release ↗
Q4 2025Dec 31, 2025-9.0%-12.0 ptsForm 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202520.0%-11.0 ptsForm 6-K FY2025Q3 Earnings Release ↗
Q4 2024Dec 31, 20243.0%-8.0 ptsForm 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202431.0%+8.0 ptsForm 6-K FY2024Q3 Earnings Release ↗
Q4 2023Dec 31, 202311.0%+35.0 ptsForm 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 202323.0%+33.0 ptsForm 6-K FY2023Q3 Earnings Release ↗
Q4 2022Dec 31, 2022-24.0%-20.0 ptsForm 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022-10.0%+29.0 ptsForm 6-K FY2022Q3 Earnings Release ↗
Q4 2021Dec 31, 2021-4.0%-89.0 ptsForm 6-K FY2021Q4 Earnings Release ↗
Q3 2021Sep 30, 2021-39.0%–Form 6-K FY2021Q3 Earnings Release ↗
Q4 2020Dec 31, 202085.0%–Form 6-K FY2020Q4 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca FluMist / Fluenz (influenza vaccine) — Worldwide YoY CER (%) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_flumist_world_cer_yoy

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.